Peter AttiaMD · longevity physician, founder of Early Medical
No. The case is still theoretical, and the human results claiming benefit do not hold up.
What it rests onConcedes NAD declines with age and that NMN raises circulating NAD, but argues intracellular NAD is the variable that matters, that human studies conflict, and that the trial showing benefits used an unvalidated biological-age calculator and a six-minute walk test that cannot detect fitness differences in healthy adults.
Source: peterattiamd.com ↗
